Entity Type
Company
Filer Snapshot
PMV Pharmaceuticals, Inc. SEC EDGAR Filings
SEC filings, ownership reports, and insider transactions for CIK 0001699382.
Total Filings
364
Latest Filing
09 Mar 2026
Industry
Pharmaceutical Preparations
Save this filer page for the next filing cycle
Keep this page in your research queue, then return to compare new filings with prior context.
Save and revisit
Save this filer page
Create a free account to keep this page in your watchlists and return after a new SEC filing changes the record here.
Best next steps
Start with the latest filings table, then open the strongest context page for this filer.
- Use the filings table to verify the newest submission, form type, and report period.
- Open the deeper context page only when this filer actually has insider or ownership signal.
Source: SEC Forms 3/4/5
View Source Filing
4 filed on 09 Mar 2026 for CIK 0001699382.
- Symbol
- PMVP on Nasdaq
- Business address
- 400 Alexander Park Drive, Suite 301, Princeton, NJ, 08540
- State of incorporation
- DE
- Fiscal year end
- 31 December
Quick Takeaways
- PMV Pharmaceuticals, Inc. is an SEC filer tracked under CIK 0001699382.
- 364 filings are listed on this profile.
- Common form coverage includes 4, S-8, 8-K and more.
What Changed
- Latest filing: 4 filed on 09 Mar 2026.
- Report period: 05 Mar 2026.
Why This Matters
- You can quote filing dates and form types directly from the SEC record on this page.
- Use this profile before deeper ownership or insider analysis to confirm filing history context.
Source Evidence
Source: SEC Forms 3/4/5
View Source Filing
4 filed on 09 Mar 2026 for CIK 0001699382.
Return Loop
Why revisit this filer page
A newly filed 4 can change the filing history, ownership context, or next research path for PMV Pharmaceuticals, Inc..
- Latest source-backed update
- 4 filed 09 Mar 2026
- Why come back
- Revisit after a new SEC filing appears to compare the updated record with prior filings.
- Latest filing on record: 4 filed 09 Mar 2026.
- Save this filer if you want a stable place to return after the next filing cycle.
- Open the latest filing table or ownership context to verify what changed.
Filer freshness comes from SEC EDGAR submission history and related source-backed ownership or portfolio filings when available.
Latest update
What changed recently for PMV Pharmaceuticals, Inc.
Latest financial period: Q4 2025. Open the source-backed page to inspect the fresh filing or facts context.
Update date
06 Mar 2026
Page type
Company facts
Latest period
Q4 2025
SEC-backed company facts were refreshed from filings filed on 06 Mar 2026.
Benchmark Context
Benchmark context for this company
PMV Pharmaceuticals, Inc. has a source-backed company facts view where you can compare the latest reported metrics with its own recent history and with peer rankings for the same metric.
Compared with
Start on the facts page for period-to-period context, then open a metric ranking when you want to compare the same reported fact across other SEC-reporting companies.
Why this is notable
Latest financial period: Q4 2025. That gives you a fresh baseline before you compare this company with peers.
- Latest company facts filing date: 06 Mar 2026.
- Peer comparisons stay conservative: same metric, compatible units, latest valid company row only.
- Open the facts page first if you want the cleanest path to verification.
Benchmark context is only shown where the app has enough comparable SEC-backed data to keep the interpretation honest.
Filer Overview
PMV Pharmaceuticals, Inc. has filed 364 SEC EDGAR filings since 02 Mar 2017. Common forms include 4, S-8, 8-K, 10-K and more.
Latest Filings
Recent SEC filings for PMV Pharmaceuticals, Inc. with direct links to document and filing folders.
| Form type | Document | Filing | Description | Filing date | Reporting date | File number(s) |
|---|---|---|---|---|---|---|
| 4 | Open 4 document | View SEC filing for 4 | 09 Mar 2026 | 05 Mar 2026 | ||
| 4 | Open 4 document | View SEC filing for 4 | 09 Mar 2026 | 05 Mar 2026 | ||
| 4 | Open 4 document | View SEC filing for 4 | 09 Mar 2026 | 05 Mar 2026 | ||
| 4 | Open 4 document | View SEC filing for 4 | 09 Mar 2026 | 05 Mar 2026 | ||
| S-8 | Open S-8 document | Open XBRL data | View SEC filing for S-8 | S-8 | 06 Mar 2026 | 333-294078 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 06 Mar 2026 | 06 Mar 2026 | 001-39539 |
| 10-K | Open 10-K document | Open XBRL data | View SEC filing for 10-K | 10-K | 06 Mar 2026 | 31 Dec 2025 | 001-39539 |
| SCHEDULE 13D/A | Open SCHEDULE 13D/A document | View SEC filing for SCHEDULE 13D/A | 04 Mar 2026 | 005-91714 | ||
| SCHEDULE 13G/A | Open SCHEDULE 13G/A document | View SEC filing for SCHEDULE 13G/A | 17 Feb 2026 | 005-91714 | ||
| SCHEDULE 13G/A | Open SCHEDULE 13G/A document | View SEC filing for SCHEDULE 13G/A | 09 Feb 2026 | 005-91714 | ||
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 12 Nov 2025 | 30 Sep 2025 | 001-39539 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 12 Nov 2025 | 12 Nov 2025 | 001-39539 |
| SCHEDULE 13G/A | Open SCHEDULE 13G/A document | View SEC filing for SCHEDULE 13G/A | 12 Nov 2025 | 005-91714 | ||
| 4 | Open 4 document | View SEC filing for 4 | 29 Oct 2025 | 27 Oct 2025 | ||
| 4 | Open 4 document | View SEC filing for 4 | 27 Oct 2025 | 23 Oct 2025 | ||
| SCHEDULE 13D/A | Open SCHEDULE 13D/A document | View SEC filing for SCHEDULE 13D/A | 27 Oct 2025 | 005-91714 | ||
| 144 | Open 144 document | View SEC filing for 144 | 23 Oct 2025 | 001-39539 | ||
| SCHEDULE 13G | Open SCHEDULE 13G document | View SEC filing for SCHEDULE 13G | 23 Sep 2025 | 005-91714 | ||
| 4 | Open 4 document | View SEC filing for 4 | 12 Sep 2025 | 10 Sep 2025 | ||
| 144 | Open 144 document | View SEC filing for 144 | 10 Sep 2025 | 001-39539 | ||
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 10 Sep 2025 | 10 Sep 2025 | 001-39539 |
| SCHEDULE 13G/A | Open SCHEDULE 13G/A document | View SEC filing for SCHEDULE 13G/A | 14 Aug 2025 | 005-91714 | ||
| SCHEDULE 13G/A | Open SCHEDULE 13G/A document | View SEC filing for SCHEDULE 13G/A | 13 Aug 2025 | 005-91714 | ||
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 07 Aug 2025 | 30 Jun 2025 | 001-39539 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 07 Aug 2025 | 07 Aug 2025 | 001-39539 |
| 4 | Open 4 document | View SEC filing for 4 | 03 Jul 2025 | 01 Jul 2025 | ||
| 4 | Open 4 document | View SEC filing for 4 | 03 Jul 2025 | 01 Jul 2025 | ||
| 4 | Open 4 document | View SEC filing for 4 | 03 Jul 2025 | 01 Jul 2025 | ||
| 4 | Open 4 document | View SEC filing for 4 | 03 Jul 2025 | 01 Jul 2025 | ||
| 4 | Open 4 document | View SEC filing for 4 | 09 Jun 2025 | 05 Jun 2025 | ||
| 4 | Open 4 document | View SEC filing for 4 | 09 Jun 2025 | 05 Jun 2025 | ||
| 4 | Open 4 document | View SEC filing for 4 | 09 Jun 2025 | 05 Jun 2025 | ||
| 4 | Open 4 document | View SEC filing for 4 | 09 Jun 2025 | 05 Jun 2025 | ||
| 4 | Open 4 document | View SEC filing for 4 | 09 Jun 2025 | 05 Jun 2025 | ||
| 4 | Open 4 document | View SEC filing for 4 | 09 Jun 2025 | 05 Jun 2025 | ||
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 09 Jun 2025 | 05 Jun 2025 | 001-39539 |
| SCHEDULE 13G/A | Open SCHEDULE 13G/A document | View SEC filing for SCHEDULE 13G/A | 15 May 2025 | 005-91714 | ||
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 09 May 2025 | 31 Mar 2025 | 001-39539 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 09 May 2025 | 09 May 2025 | 001-39539 |
| ARS | Open ARS document | View SEC filing for ARS | ARS | 25 Apr 2025 | 31 Dec 2024 | 001-39539 |
| DEFA14A | Open DEFA14A document | View SEC filing for DEFA14A | DEFA14A | 25 Apr 2025 | 001-39539 | |
| DEF 14A | Open DEF 14A document | Open XBRL data | View SEC filing for DEF 14A | DEF 14A | 25 Apr 2025 | 05 Jun 2025 | 001-39539 |
| 3 | Open 3 document | View SEC filing for 3 | 23 Apr 2025 | 21 Apr 2025 | ||
| SCHEDULE 13G | Open SCHEDULE 13G document | View SEC filing for SCHEDULE 13G | 08 Apr 2025 | 005-91714 | ||
| 4 | Open 4 document | View SEC filing for 4 | 05 Mar 2025 | 03 Mar 2025 | ||
| 4 | Open 4 document | View SEC filing for 4 | 05 Mar 2025 | 03 Mar 2025 | ||
| 4 | Open 4 document | View SEC filing for 4 | 05 Mar 2025 | 03 Mar 2025 | ||
| 10-K | Open 10-K document | Open XBRL data | View SEC filing for 10-K | 10-K | 03 Mar 2025 | 31 Dec 2024 | 001-39539 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 03 Mar 2025 | 03 Mar 2025 | 001-39539 |
| SCHEDULE 13G | Open SCHEDULE 13G document | View SEC filing for SCHEDULE 13G | 21 Feb 2025 | 005-91714 | ||
| SCHEDULE 13G/A | Open SCHEDULE 13G/A document | View SEC filing for SCHEDULE 13G/A | 14 Feb 2025 | 005-91714 | ||
| SCHEDULE 13G/A | Open SCHEDULE 13G/A document | View SEC filing for SCHEDULE 13G/A | 14 Feb 2025 | 005-91714 | ||
| SCHEDULE 13G | Open SCHEDULE 13G document | View SEC filing for SCHEDULE 13G | 10 Feb 2025 | 005-91714 | ||
| S-8 | Open S-8 document | View SEC filing for S-8 | S-8 | 28 Jan 2025 | 333-284560 | |
| 4 | Open 4 document | View SEC filing for 4 | 22 Jan 2025 | 03 Dec 2024 | ||
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | 12 Dec 2024 | 005-91714 | ||
| EFFECT | Open EFFECT document | View SEC filing for EFFECT | 27 Nov 2024 | 333-283349 | ||
| 424B3 | Open 424B3 document | View SEC filing for 424B3 | 424B3 | 27 Nov 2024 | 333-283349 | |
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 25 Nov 2024 | |||
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 25 Nov 2024 | 333-283349 | ||
| S-3 | Open S-3 document | View SEC filing for S-3 | S-3 | 20 Nov 2024 | 333-283349 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | 14 Nov 2024 | 005-91714 | ||
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 07 Nov 2024 | 30 Sep 2024 | 001-39539 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 07 Nov 2024 | 07 Nov 2024 | 001-39539 |
| 4 | Open 4 document | View SEC filing for 4 | 03 Oct 2024 | 13 Aug 2024 | ||
| 4 | Open 4 document | View SEC filing for 4 | 03 Oct 2024 | 13 Aug 2024 | ||
| 4 | Open 4 document | View SEC filing for 4 | 03 Oct 2024 | 13 Aug 2024 | ||
| 4 | Open 4 document | View SEC filing for 4 | 12 Sep 2024 | 11 Sep 2024 | ||
| 4 | Open 4 document | View SEC filing for 4 | 12 Sep 2024 | 11 Sep 2024 | ||
| SC TO-I/A | Open SC TO-I/A document | View SEC filing for SC TO-I/A | SC TO-I/A | 14 Aug 2024 | 005-91714 | |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 08 Aug 2024 | 30 Jun 2024 | 001-39539 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 08 Aug 2024 | 05 Aug 2024 | 001-39539 |
| SC TO-I | Open SC TO-I document | View SEC filing for SC TO-I | SC TO-I | 16 Jul 2024 | 005-91714 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | 08 Jul 2024 | 005-91714 | ||
| 4 | Open 4 document | View SEC filing for 4 | 10 Jun 2024 | 06 Jun 2024 | ||
| 4 | Open 4 document | View SEC filing for 4 | 10 Jun 2024 | 06 Jun 2024 | ||
| 4 | Open 4 document | View SEC filing for 4 | 10 Jun 2024 | 06 Jun 2024 | ||
| 4 | Open 4 document | View SEC filing for 4 | 10 Jun 2024 | 06 Jun 2024 | ||
| 4 | Open 4 document | View SEC filing for 4 | 10 Jun 2024 | 06 Jun 2024 | ||
| 4 | Open 4 document | View SEC filing for 4 | 10 Jun 2024 | 06 Jun 2024 | ||
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 07 Jun 2024 | 06 Jun 2024 | 001-39539 |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 09 May 2024 | 31 Mar 2024 | 001-39539 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 09 May 2024 | 09 May 2024 | 001-39539 |
| ARS | Open ARS document | View SEC filing for ARS | ARS | 24 Apr 2024 | 31 Dec 2023 | 001-39539 |
| DEFA14A | Open DEFA14A document | View SEC filing for DEFA14A | DEFA14A | 24 Apr 2024 | 001-39539 | |
| DEF 14A | Open DEF 14A document | View SEC filing for DEF 14A | DEF 14A | 24 Apr 2024 | 06 Jun 2024 | 001-39539 |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | FILING PMV PHARMACEUTICALS, INC. | 09 Apr 2024 | 005-91714 | |
| 10-K | Open 10-K document | Open XBRL data | View SEC filing for 10-K | 10-K | 29 Feb 2024 | 31 Dec 2023 | 001-39539 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 29 Feb 2024 | 29 Feb 2024 | 001-39539 |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SC 13G/A | 14 Feb 2024 | 005-91714 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | 14 Feb 2024 | 005-91714 | ||
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | 14 Feb 2024 | 005-91714 | ||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | PMV PHARMACEUTICALS, INC. | 14 Feb 2024 | 005-91714 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | PMV PHARMACEUTICALS, INC. | 14 Feb 2024 | 005-91714 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SCHEDULE 13G/A | 13 Feb 2024 | 005-91714 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | 29 Jan 2024 | 005-91714 | ||
| S-8 | Open S-8 document | View SEC filing for S-8 | S-8 | 24 Jan 2024 | 333-276667 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | FILING PMV PHARMACEUTICALS, INC. | 23 Jan 2024 | 005-91714 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | 23 Jan 2024 | 005-91714 | ||
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 22 Jan 2024 | 18 Jan 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 22 Jan 2024 | 18 Jan 2024 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 22 Jan 2024 | 18 Jan 2024 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 18 Jan 2024 | 18 Jan 2024 | 001-39539 |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 11 Jan 2024 | 05 Jan 2024 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 05 Jan 2024 | 04 Jan 2024 | 001-39539 |
| 4 | Open 4 document | View SEC filing for 4 | 24 Nov 2023 | 22 Nov 2023 | ||
| 144 | Open 144 document | View SEC filing for 144 | 22 Nov 2023 | 001-39539 | ||
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 13 Nov 2023 | 18 Oct 2023 | |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 09 Nov 2023 | 30 Sep 2023 | 001-39539 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 09 Nov 2023 | 09 Nov 2023 | 001-39539 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 12 Oct 2023 | 12 Oct 2023 | 001-39539 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 11 Oct 2023 | 11 Oct 2023 | 001-39539 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 18 Sep 2023 | 15 Sep 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 18 Sep 2023 | 15 Sep 2023 | |
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | AMENDMENT NO. 2 | 23 Aug 2023 | 005-91714 | |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 09 Aug 2023 | 30 Jun 2023 | 001-39539 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 09 Aug 2023 | 09 Aug 2023 | 001-39539 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Aug 2023 | 07 Aug 2023 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | 07 Jul 2023 | 005-91714 | ||
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 12 Jun 2023 | 08 Jun 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 12 Jun 2023 | 08 Jun 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 12 Jun 2023 | 08 Jun 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 12 Jun 2023 | 08 Jun 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 12 Jun 2023 | 08 Jun 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 12 Jun 2023 | 08 Jun 2023 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 09 Jun 2023 | 08 Jun 2023 | 001-39539 |
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | SC 13G | 19 May 2023 | 005-91714 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 15 May 2023 | 12 May 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 15 May 2023 | 12 May 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 15 May 2023 | 12 May 2023 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 15 May 2023 | 12 May 2023 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | 10 May 2023 | 005-91714 | ||
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 10 May 2023 | 31 Mar 2023 | 001-39539 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 10 May 2023 | 10 May 2023 | 001-39539 |
| EFFECT | Open EFFECT document | View SEC filing for EFFECT | 28 Apr 2023 | 333-260012 | ||
| ARS | Open ARS document | View SEC filing for ARS | ARS | 28 Apr 2023 | 31 Dec 2022 | 001-39539 |
| DEFA14A | Open DEFA14A document | View SEC filing for DEFA14A | DEFA14A | 28 Apr 2023 | 001-39539 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 28 Apr 2023 | 24 Apr 2023 | 001-39539 |
| DEF 14A | Open DEF 14A document | View SEC filing for DEF 14A | DEF14A | 28 Apr 2023 | 08 Jun 2023 | 001-39539 |
| POS AM | Open POS AM document | View SEC filing for POS AM | POS AM | 01 Mar 2023 | 333-260012 | |
| 10-K | Open 10-K document | Open XBRL data | View SEC filing for 10-K | 10-K | 01 Mar 2023 | 31 Dec 2022 | 001-39539 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 01 Mar 2023 | 01 Mar 2023 | 001-39539 |
| POSASR | Open POSASR document | View SEC filing for POSASR | POSASR | 01 Mar 2023 | 333-260012 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | 14 Feb 2023 | 005-91714 | ||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | PMV PHARMACEUTICALS, INC. | 14 Feb 2023 | 005-91714 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | PMV PHARMACEUTICALS, INC. | 14 Feb 2023 | 005-91714 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SC 13G/A | 14 Feb 2023 | 005-91714 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SC 13G/A | 10 Feb 2023 | 005-91714 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | 10 Feb 2023 | 005-91714 | ||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SCHEDULE 13G/A | 09 Feb 2023 | 005-91714 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | 31 Jan 2023 | 005-91714 | ||
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 30 Jan 2023 | 25 Nov 2022 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | FILING PMV PHARMACEUTICALS, INC. | 25 Jan 2023 | 005-91714 | |
| S-8 | Open S-8 document | View SEC filing for S-8 | S-8 | 25 Jan 2023 | 333-269394 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | COWEN FINANCIAL PRODUCTS LLC | 24 Jan 2023 | 005-91714 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Nov 2022 | 04 Nov 2022 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 08 Nov 2022 | 03 Nov 2022 | |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 08 Nov 2022 | 30 Sep 2022 | 001-39539 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 08 Nov 2022 | 08 Nov 2022 | 001-39539 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 04 Nov 2022 | 03 Nov 2022 | 001-39539 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 13 Sep 2022 | 09 Sep 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 13 Sep 2022 | 09 Sep 2022 | |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 09 Aug 2022 | 30 Jun 2022 | 001-39539 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 09 Aug 2022 | 09 Aug 2022 | 001-39539 |
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | 11 Jul 2022 | 005-91714 | ||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | FILING PMV PHARMACEUTICALS, INC. | 07 Jul 2022 | 005-91714 | |
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | PMV PHARMACEUTICALS, INC. | 17 Jun 2022 | 005-91714 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 08 Jun 2022 | 07 Jun 2022 | 001-39539 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 06 Jun 2022 | 02 Jun 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 06 Jun 2022 | 02 Jun 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 06 Jun 2022 | 02 Jun 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 06 Jun 2022 | 02 Jun 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 06 Jun 2022 | 02 Jun 2022 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 06 Jun 2022 | 02 Jun 2022 | 001-39539 |
| 4 | Open 4 document | View SEC filing for 4 | 31 May 2022 | 26 May 2022 | ||
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 26 May 2022 | 26 May 2022 | 001-39539 |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 10 May 2022 | 31 Mar 2022 | 001-39539 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 10 May 2022 | 10 May 2022 | 001-39539 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 29 Apr 2022 | 27 Apr 2022 | |
| DEFA14A | Open DEFA14A document | View SEC filing for DEFA14A | DEFA14A | 22 Apr 2022 | 001-39539 | |
| DEF 14A | Open DEF 14A document | View SEC filing for DEF 14A | DEF 14A | 22 Apr 2022 | 02 Jun 2022 | 001-39539 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 21 Apr 2022 | 20 Apr 2022 | |
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | AMENDMENT NO. 1 | 01 Apr 2022 | 005-91714 | |
| 4 | Open 4 document | View SEC filing for 4 | 31 Mar 2022 | 29 Mar 2022 | ||
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 09 Mar 2022 | 08 Mar 2022 | |
| 10-K | Open 10-K document | Open XBRL data | View SEC filing for 10-K | 10-K | 01 Mar 2022 | 31 Dec 2021 | 001-39539 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 01 Mar 2022 | 01 Mar 2022 | 001-39539 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 28 Feb 2022 | 10 Feb 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 28 Feb 2022 | 10 Feb 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 28 Feb 2022 | 10 Feb 2022 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 28 Feb 2022 | 10 Feb 2022 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SC 13G/A | 14 Feb 2022 | 005-91714 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SC 13G/A | 14 Feb 2022 | 005-91714 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SC 13G/A | 14 Feb 2022 | 005-91714 | |
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | PMV PHARMACEUTICALS, INC. | 14 Feb 2022 | 005-91714 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SC 13G/A | 14 Feb 2022 | 005-91714 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SC 13G/A | 14 Feb 2022 | 005-91714 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | PMV PHARMACEUTICALS, INC. | 11 Feb 2022 | 005-91714 | |
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | SCHEDULE 13G | 10 Feb 2022 | 005-91714 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Feb 2022 | 30 Dec 2021 | |
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | 04 Feb 2022 | 005-91714 | ||
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | FILING PMV PHARMACEUTICALS, INC. | 26 Jan 2022 | 005-91714 | |
| S-8 | Open S-8 document | View SEC filing for S-8 | S-8 | 24 Jan 2022 | 333-262308 | |
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | COWEN FINANCIAL PRODUCTS LLC | 19 Jan 2022 | 005-91714 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 10 Jan 2022 | 06 Jan 2022 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 10 Jan 2022 | 05 Jan 2022 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | FORM 8-K | 06 Jan 2022 | 05 Jan 2022 | 001-39539 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 16 Dec 2021 | 15 Dec 2021 | |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 12 Nov 2021 | 30 Sep 2021 | 001-39539 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | 8-K | 12 Nov 2021 | 12 Nov 2021 | 001-39539 |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SC 13G/A | 18 Oct 2021 | 005-91714 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Oct 2021 | 06 Oct 2021 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | FORM 8-K | 05 Oct 2021 | 04 Oct 2021 | 001-39539 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 04 Oct 2021 | 30 Sep 2021 | |
| S-3ASR | Open S-3ASR document | View SEC filing for S-3ASR | S-3ASR | 04 Oct 2021 | 333-260012 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 29 Sep 2021 | 27 Sep 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 24 Sep 2021 | 22 Sep 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 23 Sep 2021 | 22 Sep 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 21 Sep 2021 | 17 Sep 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 13 Sep 2021 | 09 Sep 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 10 Sep 2021 | 09 Sep 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Sep 2021 | 07 Sep 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 02 Sep 2021 | 31 Aug 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 30 Aug 2021 | 26 Aug 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 25 Aug 2021 | 23 Aug 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 24 Aug 2021 | 23 Aug 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 20 Aug 2021 | 18 Aug 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 20 Aug 2021 | 19 Aug 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 20 Aug 2021 | 19 Aug 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 18 Aug 2021 | 17 Aug 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 17 Aug 2021 | 13 Aug 2021 | |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 13 Aug 2021 | 30 Jun 2021 | 001-39539 |
| 8-K | Open 8-K document | View SEC filing for 8-K | 8-K | 13 Aug 2021 | 13 Aug 2021 | 001-39539 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 12 Aug 2021 | 10 Aug 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 10 Aug 2021 | 09 Aug 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 09 Aug 2021 | 05 Aug 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 04 Aug 2021 | 02 Aug 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 04 Aug 2021 | 03 Aug 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 30 Jul 2021 | 28 Jul 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 27 Jul 2021 | 23 Jul 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 23 Jul 2021 | 21 Jul 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 23 Jul 2021 | 12 May 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 22 Jul 2021 | 12 May 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 22 Jul 2021 | 20 Jul 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 14 Jul 2021 | 13 Jul 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Jul 2021 | 08 Jul 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Jul 2021 | 07 Jul 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 29 Jun 2021 | 28 Jun 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 22 Jun 2021 | 21 Jun 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 15 Jun 2021 | 11 Jun 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 11 Jun 2021 | 09 Jun 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 09 Jun 2021 | 07 Jun 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 09 Jun 2021 | 02 Jun 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 09 Jun 2021 | 02 Jun 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 09 Jun 2021 | 02 Jun 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 09 Jun 2021 | 02 Jun 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 09 Jun 2021 | 02 Jun 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Jun 2021 | 12 May 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Jun 2021 | 12 May 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Jun 2021 | 12 May 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Jun 2021 | 12 May 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 07 Jun 2021 | 04 Jun 2021 | |
| 8-K | Open 8-K document | View SEC filing for 8-K | 8-K | 07 Jun 2021 | 02 Jun 2021 | 001-39539 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 04 Jun 2021 | 03 Jun 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 02 Jun 2021 | 28 May 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 02 Jun 2021 | 01 Jun 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 27 May 2021 | 25 May 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 24 May 2021 | 20 May 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 24 May 2021 | 20 May 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 21 May 2021 | 20 May 2021 | |
| S-8 | Open S-8 document | View SEC filing for S-8 | FORM S-8 | 21 May 2021 | 333-256346 | |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 14 May 2021 | 31 Mar 2021 | 001-39539 |
| 8-K | Open 8-K document | View SEC filing for 8-K | 8-K | 14 May 2021 | 14 May 2021 | 001-39539 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 12 May 2021 | 10 May 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 12 May 2021 | 10 May 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 10 May 2021 | 07 May 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 07 May 2021 | 05 May 2021 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SC 13G/A | 07 May 2021 | 005-91714 | |
| 3 | Open 3 document | View SEC filing for 3 | INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES | 07 May 2021 | 28 Apr 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 04 May 2021 | 03 May 2021 | |
| DEFA14A | Open DEFA14A document | View SEC filing for DEFA14A | DEFA14A | 23 Apr 2021 | 001-39539 | |
| DEF 14A | Open DEF 14A document | View SEC filing for DEF 14A | DEF 14A | 23 Apr 2021 | 02 Jun 2021 | 001-39539 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 13 Apr 2021 | 09 Apr 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Apr 2021 | 06 Apr 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 08 Apr 2021 | 07 Apr 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 07 Apr 2021 | 05 Apr 2021 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 07 Apr 2021 | 01 Apr 2021 | |
| 8-K | Open 8-K document | View SEC filing for 8-K | 8-K | 06 Apr 2021 | 01 Apr 2021 | 001-39539 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 05 Apr 2021 | 01 Apr 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 31 Mar 2021 | 29 Mar 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 26 Mar 2021 | 24 Mar 2021 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 25 Mar 2021 | 24 Mar 2021 | |
| 10-K | Open 10-K document | Open XBRL data | View SEC filing for 10-K | 10-K | 03 Mar 2021 | 31 Dec 2020 | 001-39539 |
| 8-K | Open 8-K document | View SEC filing for 8-K | 8-K | 03 Mar 2021 | 03 Mar 2021 | 001-39539 |
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | SC 13G | 16 Feb 2021 | 005-91714 | |
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | AMENDMENT NO. 1 | 16 Feb 2021 | 005-91714 | |
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | SC 13G | 12 Feb 2021 | 005-91714 | |
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | PMV PHARMACEUTICALS, INC. | 12 Feb 2021 | 005-91714 | |
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | SC 13G | 12 Feb 2021 | 005-91714 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 31 Dec 2020 | 08 Dec 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 20 Nov 2020 | 18 Nov 2020 | |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | 10-Q | 13 Nov 2020 | 30 Sep 2020 | 001-39539 |
| 8-K | Open 8-K document | View SEC filing for 8-K | 8-K | 13 Nov 2020 | 13 Nov 2020 | 001-39539 |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 12 Nov 2020 | 11 Nov 2020 | |
| SC 13D | Open SC 13D document | View SEC filing for SC 13D | SCHEDULE 13D | 05 Oct 2020 | 005-91714 | |
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | ACQUISITION OF BENEFICIAL OWNERSHIP | 05 Oct 2020 | 005-91714 | |
| 4/A | Open 4/A document | View SEC filing for 4/A | FORM 4/A SUBMISSION | 02 Oct 2020 | 25 Sep 2020 | |
| 4/A | Open 4/A document | View SEC filing for 4/A | FORM 4/A SUBMISSION | 02 Oct 2020 | 25 Sep 2020 | |
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | SC 13G | 30 Sep 2020 | 005-91714 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 29 Sep 2020 | 29 Sep 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 29 Sep 2020 | 29 Sep 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 29 Sep 2020 | 29 Sep 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 29 Sep 2020 | 29 Sep 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 29 Sep 2020 | 29 Sep 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 29 Sep 2020 | 29 Sep 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 29 Sep 2020 | 25 Sep 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 29 Sep 2020 | 25 Sep 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 29 Sep 2020 | 25 Sep 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 29 Sep 2020 | 29 Sep 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 29 Sep 2020 | 25 Sep 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 29 Sep 2020 | 25 Sep 2020 | |
| 3/A | Open 3/A document | View SEC filing for 3/A | FORM 3/A SUBMISSION | 29 Sep 2020 | 24 Sep 2020 | |
| 4 | Open 4 document | View SEC filing for 4 | OWNERSHIP DOCUMENT | 29 Sep 2020 | 29 Sep 2020 | |
| 8-K | Open 8-K document | View SEC filing for 8-K | 8-K | 29 Sep 2020 | 29 Sep 2020 | 001-39539 |
| S-8 | Open S-8 document | View SEC filing for S-8 | S-8 | 28 Sep 2020 | 333-249094 | |
| 424B4 | Open 424B4 document | View SEC filing for 424B4 | 424B4 | 25 Sep 2020 | 333-248627 | |
| EFFECT | Open EFFECT document | View SEC filing for EFFECT | 24 Sep 2020 | 333-248627 | ||
| 3 | Open 3 document | View SEC filing for 3 | OWNERSHIP DOCUMENT | 24 Sep 2020 | 24 Sep 2020 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 24 Sep 2020 | 24 Sep 2020 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 24 Sep 2020 | 24 Sep 2020 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 24 Sep 2020 | 24 Sep 2020 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 24 Sep 2020 | 24 Sep 2020 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 24 Sep 2020 | 24 Sep 2020 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 24 Sep 2020 | 24 Sep 2020 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 24 Sep 2020 | 24 Sep 2020 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 24 Sep 2020 | 24 Sep 2020 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 24 Sep 2020 | 24 Sep 2020 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 24 Sep 2020 | 24 Sep 2020 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 24 Sep 2020 | 24 Sep 2020 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 24 Sep 2020 | 24 Sep 2020 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 24 Sep 2020 | 24 Sep 2020 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 24 Sep 2020 | 24 Sep 2020 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 24 Sep 2020 | 24 Sep 2020 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 24 Sep 2020 | 24 Sep 2020 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 24 Sep 2020 | 24 Sep 2020 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 24 Sep 2020 | 24 Sep 2020 | |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 24 Sep 2020 | 24 Sep 2020 | |
| CERT | Open CERT document | View SEC filing for CERT | 24 Sep 2020 | 001-39539 | ||
| S-1/A | Open S-1/A document | View SEC filing for S-1/A | S-1/A | 24 Sep 2020 | 333-248627 | |
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 22 Sep 2020 | |||
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 22 Sep 2020 | |||
| 8-A12B | Open 8-A12B document | View SEC filing for 8-A12B | 8-A12B | 21 Sep 2020 | 001-39539 | |
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 21 Sep 2020 | |||
| S-1/A | Open S-1/A document | View SEC filing for S-1/A | S-1/A | 21 Sep 2020 | 333-248627 | |
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 17 Sep 2020 | |||
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 11 Sep 2020 | |||
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 04 Sep 2020 | |||
| S-1 | Open S-1 document | View SEC filing for S-1 | S-1 | 04 Sep 2020 | 333-248627 | |
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 18 Aug 2020 | |||
| DRS/A | Open DRS/A document | View SEC filing for DRS/A | 03 Aug 2020 | 377-03247 | ||
| DRSLTR | Open DRSLTR document | View SEC filing for DRSLTR | 31 Jul 2020 | |||
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 23 Jul 2020 | |||
| DRS | Open DRS document | View SEC filing for DRS | 26 Jun 2020 | 377-03247 | ||
| D | Open D document | View SEC filing for D | 02 Mar 2017 | 021-281658 |
About this filer
PMV Pharmaceuticals, Inc. files with the SEC under CIK 0001699382. This page aggregates EDGAR filings and related ownership activity.
Industry: Pharmaceutical Preparations.
FAQ
- What is a CIK?
- A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
- Why are some filings missing?
- New filings appear as the SEC updates EDGAR, and older records can vary by availability.
- How often is this page updated?
- Updates follow new EDGAR submissions and periodic data refreshes.